Autoimmune Diseases of the Nervous System
"Autoimmune Diseases of the Nervous System" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders caused by cellular or humoral immune responses primarily directed towards nervous system autoantigens. The immune response may be directed towards specific tissue components (e.g., myelin) and may be limited to the central nervous system (e.g., MULTIPLE SCLEROSIS) or the peripheral nervous system (e.g., GUILLAIN-BARRE SYNDROME).
| Descriptor ID |
D020274
|
| MeSH Number(s) |
C10.114 C20.111.258
|
| Concept/Terms |
Autoimmune Diseases of the Nervous System- Autoimmune Diseases of the Nervous System
- Autoimmune Diseases, Neurologic
- Autoimmune Disease, Neurologic
- Disease, Neurologic Autoimmune
- Diseases, Neurologic Autoimmune
- Neurologic Autoimmune Disease
- Neurologic Autoimmune Diseases
- Autoimmune Disorders, Nervous System
- Autoimmune Nervous System Diseases
- Nervous System Autoimmune Diseases
- Autoimmune Diseases, Nervous System
- Autoimmune Disorders of the Nervous System
|
Below are MeSH descriptors whose meaning is more general than "Autoimmune Diseases of the Nervous System".
Below are MeSH descriptors whose meaning is more specific than "Autoimmune Diseases of the Nervous System".
This graph shows the total number of publications written about "Autoimmune Diseases of the Nervous System" by people in this website by year, and whether "Autoimmune Diseases of the Nervous System" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 3 | 0 | 3 |
| 2012 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Autoimmune Diseases of the Nervous System" by people in Profiles.
-
Querol L, Dalakas MC. The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology. Neurol Neuroimmunol Neuroinflamm. 2025 Jan; 12(1):e200365.
-
Dalakas MC. Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy. Neurotherapeutics. 2021 10; 18(4):2397-2418.
-
Dalakas MC. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. 2020 09; 7(5).
-
Maurer MA, Rakocevic G, Leung CS, Quast I, Lukacišin M, Goebels N, Münz C, Wardemann H, Dalakas M, Lünemann JD. Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity. J Clin Invest. 2012 Apr 2; 122(4):1393-402.
-
Dalakas MC. B cells as therapeutic targets in autoimmune neurological disorders. Nat Clin Pract Neurol. 2008 Oct; 4(10):557-67.
-
Dalakas M. IVIg in other autoimmune neurological disorders: current status and future prospects. J Neurol. 2008 Jul; 255 Suppl 3:12-6.
-
Dalakas MC. Invited article: inhibition of B cell functions: implications for neurology. Neurology. 2008 Jun 3; 70(23):2252-60.
-
Dalakas MC. Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects. J Neurol. 2006 Sep; 253 Suppl 5:V25-32.
-
Dalakas MC. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther. 2004 Jun; 102(3):177-93.
-
Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA. 2004 May 19; 291(19):2367-75.